Screener
Bausch Health Companies BHC Solta Medical — Operating Income (Loss)
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Bausch Health Companies in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The source filing: Bausch Health Companies’s 10-Q, filed April 30, 2026.
- Filed
- Apr 29, 2026, 6:12 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000885590-26-000053
| (in millions) | Three Months Ended March 31, / Salix / 2026 | Three Months Ended March 31, / Salix / 2025 | Three Months Ended March 31, / International / 2026 | Three Months Ended March 31, / International / 2025 | Three Months Ended March 31, / Solta Medical / 2026 | Three Months Ended March 31, / Solta Medical / 2025 | Three Months Ended March 31, / Diversified / 2026 | Three Months Ended March 31, / Diversified / 2025 | Three Months Ended March 31, / Bausch + Lomb / 2026 | Three Months Ended March 31, / Bausch + Lomb / 2025 | Three Months Ended March 31, / Total / 2026 | Total / 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cost of other revenues | — | — | 16 | 17 | — | — | — | — | 1 | 1 | ||
| Selling, general and administrative | 105 | 111 | 63 | 52 | 35 | 28 | 43 | 45 | 439 | 447 | ||
| Research and development | 19 | 17 | 6 | 6 | 8 | 5 | 3 | 3 | 45 | 28 | ||
| Segment profit | $468 | $371 | $88 | $85 | $75 | $53 | $112 | $127 | $277 | $180 | $1,020 | $816 |
| Corporate | (258) | (268) | ||||||||||
| Amortization of intangible assets | (241) | (256) | ||||||||||
| Goodwill impairments | (1,426) | — | ||||||||||
| Restructuring, integration and separation costs | (13) | (1) |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is Bausch Health Companies's solta medical — operating income (loss)?
- Bausch Health Companies (BHC) reported solta medical — operating income (loss) of $75M in Q1 2026.
- How has Bausch Health Companies's solta medical — operating income (loss) changed year-over-year?
- Bausch Health Companies's solta medical — operating income (loss) increased by 41.5% year-over-year, from $53M to $75M.
- What is the long-term trend for Bausch Health Companies's solta medical — operating income (loss)?
- Over 4 years (2021 to 2025), Bausch Health Companies's solta medical — operating income (loss) has grown at a 8.6% compound annual growth rate (CAGR), from $167M to $232M.
- What does solta medical — operating income (loss) mean?
- Calculated as the segment's total revenue minus its direct operating expenses, including cost of goods sold, SG&A, and R&D. It serves as the primary measure of the core profitability and operational performance of the Solta Medical business unit.
Ask your AI about Bausch Health Companies's solta medical — operating income (loss).
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude